About
Biomatics Capital is a venture Capital firm dedicated to transforming health care and medicine through strategic investments. The firm is at a tipping point where the convergence of genomics and Digitaldata is enabling revolutionary advancements in therapeutics, diagnostics, and delivery models. Biomatics Capital has a savvy and nimble team with exceptional vision and execution capabilities ranging from gene editing to DNA synthesis. Their passion for groundbreaking technologies combined with their business acumen provides entrepreneurs with unparalleled support and a vital network of experts, driving the next generation of companies toward exceptional value and innovation.